Clinical trial · Interventional
Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration Spectroscopy
NCT00540852CI-TRIAL-00061834completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Optimal management of patients with locally advanced breast cancer remains a complex therapeutic problem. Newly diagnosed breast cancers in the United States with a higher incidence in medically underserved areas. The optimal intensity and duration of neoadjuvant chemotherapy still remains controversial due to the difficulty of evaluating response to therapy. The goal would be to prevent over and under treatment of patients with neoadjuvant chemotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Diffuse Optical Spectroscopy Imaging | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Diagnostic Tool
- description
- Diffuse Optical Spectroscopy Imaging
- interventionNames
- Device: Diffuse Optical Spectroscopy Imaging
Primary outcomes (1)
- measure
- Diagnostic tool
- timeFrame
- 12 weeks
- description
- Diffuse Optical Spectroscopy Imaging Breast Cancer Tumor in the response of Chemotherapy
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Female non-pregnant and age greater than or equal to 21 years old but less than 75 years old * Diagnosed with breast cancer and will be receiving neoadjuvant chemotherapy Exclusion Criteria: * Female pregnant and age less than 21 years old and have no diagnosis of breast cancer
References
Publications (0)
Data not yet available
No reference posted for this study.